dapi has been researched along with obovatol in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cho, JS; Han, SB; Hong, JT; Jung, JK; Lee, SY; Lee, YM; Moon, DC; Oh, KW; Yoo, HS; Yuk, DY | 1 |
1 other study(ies) available for dapi and obovatol
Article | Year |
---|---|
Obovatol enhances docetaxel-induced prostate and colon cancer cell death through inactivation of nuclear transcription factor-kappaB.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Biphenyl Compounds; Cell Death; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; Colonic Neoplasms; Docetaxel; Drug Synergism; Fluorescent Dyes; HCT116 Cells; Humans; In Situ Nick-End Labeling; Indoles; Inhibitory Concentration 50; Magnolia; Male; Molecular Structure; NF-kappa B; Phenyl Ethers; Plant Leaves; Prostatic Neoplasms; Taxoids | 2009 |